Director Maureen O'Connell filed a Form 4 with the SEC on September 4, 2026, disclosing the sale of a combined 33,000 shares of Acacia Research Corp common stock across two transactions on September 2 and September 3, 2026.

Key Highlights

  • Reporting person: Maureen O'Connell, listed as a Director of Acacia Research Corp (NASDAQ:ACTG).
  • First sale: 20,534 shares sold on September 2, 2026, at a weighted average price of $4.63, with individual transaction prices ranging from $4.615 to $4.645.
  • Second sale: 12,466 shares sold on September 3, 2026, at a weighted average price of $4.57, with individual transaction prices ranging from $4.51 to $4.66.
  • Remaining ownership: Following both transactions, O'Connell directly beneficially owned 254,655 shares of ACTG common stock.
  • Transaction code: Both sales were coded "S" (open-market sale) and classified as direct ownership disposals.
  • Signing: The form was signed by Jennifer Graff as attorney-in-fact on September 4, 2026.

O'Connell Disposes of ACTG Common Stock in Two Open-Market Sales

According to the filing, Maureen O'Connell, a director of Acacia Research Corp, sold shares of ACTG common stock on two consecutive trading days. On September 2, 2026, the filing discloses a disposal of 20,534 shares with a weighted average price of $4.63. The filing notes that those shares were sold in multiple transactions at prices ranging from $4.615 to $4.645, inclusive.

On September 3, 2026, the filing discloses a second disposal of 12,466 shares at a weighted average price of $4.57. Per the filing, these shares were also sold in multiple transactions, with prices ranging from $4.51 to $4.66, inclusive. Following both sales, O'Connell's directly held beneficial ownership stood at 254,655 shares, down from 287,655 shares prior to the first reported transaction, according to the sequential figures disclosed in the filing.

The filing indicates that O'Connell undertakes to provide Acacia Research Corp, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges disclosed. No derivative securities transactions were reported in Table II of the form. The form was filed by one reporting person and signed by Jennifer Graff as attorney-in-fact.

What Was Disclosed

Director Maureen O'Connell reported the open-market sale of 33,000 total shares of Acacia Research Corp common stock over September 2-3, 2026, at weighted average prices of $4.63 and $4.57 respectively, leaving her with 254,655 directly held shares.